BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31493088)

  • 1. Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancy.
    Lewis AR; Cipriano C; Wang X; Ward R; Fitzpatrick A; Scott ARM; Rashed A; Raja H; Lamarca A; Hubner RA; Valle JW; McNamara MG
    Med Oncol; 2019 Sep; 36(10):85. PubMed ID: 31493088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Rockwood Clinical Frailty Scale in patients with advanced hepatopancreaticobiliary malignancies.
    Shah D; Kapacee ZA; Lamarca A; Hubner RA; Valle JW; McNamara MG
    Expert Rev Anticancer Ther; 2022 Sep; 22(9):1009-1015. PubMed ID: 35768183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007.
    Coupland VH; Kocher HM; Berry DP; Allum W; Linklater KM; Konfortion J; Møller H; Davies EA
    Cancer Epidemiol; 2012 Aug; 36(4):e207-14. PubMed ID: 22534487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of HPB malignancy in the elderly.
    Pericleous M; Khan SA
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):503-513. PubMed ID: 32360064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.
    Murakawa Y; Sakayori M; Otsuka K
    BMC Palliat Care; 2019 Jun; 18(1):45. PubMed ID: 31159782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma.
    Chen JJ; Shah JL; Harris JP; Bui TT; Schaberg K; Kong CS; Kaplan MJ; Divi V; Schoppy D; Le QT; Hara WY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):775-783. PubMed ID: 28602409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.
    Song A; Eo W; Kim S; Shim B; Lee S
    BMC Complement Altern Med; 2018 Jun; 18(1):176. PubMed ID: 29879960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
    Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
    JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Comorbidity and Age on Determinants Therapeutic Strategies in Advanced Pancreatic Head Cancer Patients With Obstructive Jaundices.
    Chen YG; Pan HH; Dai MS; Lin C; Lu CS; Su SL; Chang PY; Huang TC; Chen JH; Wu YY; Chen YC; Ho CL
    Medicine (Baltimore); 2015 Aug; 94(31):e1298. PubMed ID: 26252308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of care and treatment outcomes in older patients with biliary tract cancer.
    Horgan A; Knox J; Aneja P; Le L; McKeever E; McNamara M
    Oncotarget; 2015 Dec; 6(42):44995-5004. PubMed ID: 26575326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal cancer in the elderly.
    Wallach CB; Kurtz RC
    Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients?
    Petrowsky H; Clavien PA
    World J Surg; 2005 Sep; 29(9):1093-100. PubMed ID: 16086216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy.
    Shao YY; Wu CH; Lu LC; Chan SY; Ma YY; Yen FC; Hsu CH; Cheng AL
    J Hepatol; 2014 Feb; 60(2):313-8. PubMed ID: 24036008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.
    Ali R; Gabr A; Abouchaleh N; Al Asadi A; Mora RA; Kulik L; Abecassis M; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):260-269. PubMed ID: 28879621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy and prognostic factors for cryoablation patients with advanced hepatocellular carcinoma].
    Chang XJ; Lu YY; Bai WL; Chen Y; An LJ; Zhou L; Wang H; Wu Y; Liu Z; Lou M; Zeng Z; Su SH; Yang YP
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):759-63. PubMed ID: 22409849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study.
    Steel JL; Kim KH; Dew MA; Unruh ML; Antoni MH; Olek MC; Geller DA; Carr BI; Butterfield LH; Gamblin TC
    J Pain Symptom Manage; 2010 May; 39(5):859-71. PubMed ID: 20471546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.